Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
Clinical trial NCT03790865 · TERMINATED
Trial details
- NCT number
- NCT03790865
- Sponsor
- Millendo Therapeutics SAS
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-25
- Primary completion
- 2020-02-26
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.